Anne Kirby

Net worth: - $ as of 2023-09-29

43 year

Health Technology

Consumer Services

Profile

Anne Kirby served as the President, CEO, Secretary & Director at Regnum Corp.
from 2021 to 2023.
Prior to that, she was the Executive Vice President-Commercial & Operations at Vyera Pharmaceuticals LLC from 2018 to 2021.
Ms. Kirby received her undergraduate degree in 2002 and her MBA in 2004 from the University of Akron.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
REGNUM CORP. -.--%	2023-04-10	0 ( -.--% )	- $	2023-09-29

Former positions of Anne Kirby

Companies	Position	End
REGNUM CORP.	Chief Executive Officer	2023-05-22
Vyera Pharmaceuticals LLC Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY.	Corporate Officer/Principal	2021-03-31

See the detail of Anne Kirby's experience

Training of Anne Kirby

University of Akron

Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Anne Kirby's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
REGNUM CORP.	Health Technology

Private companies	1
Vyera Pharmaceuticals LLC Vyera Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Vyera Pharmaceuticals LLC operates as a biopharmaceutical company that focuses on patients with unmet medical needs. Its products include Vecamyl and Daraprim. The firm engages in developing and commercializing treatments for serious diseases and conditions of therapeutic areas. The company was founded by Martin Shkreli in October 10, 2014 and is headquartered in New York, NY.	Health Technology